Core Insights - Wasatch Global Investors reported a decline of -3.17% for its fund-Investor Class in Q3 2025, underperforming the Russell 2000 Growth Index which gained 12.19% during the same period [1] - The strong performance of US small-cap equities was supported by the Federal Reserve's interest rate cut [1] Company Performance - Medpace Holdings, Inc. (NASDAQ:MEDP) was highlighted as the top contributor to the fund's performance, with a one-month return of -4.76% and a 52-week gain of 59.52% [2][3] - Medpace reported revenue of $659.9 million in Q3 2025, marking a year-over-year increase of 23.7% [4] - The company raised its full-year guidance following strong revenue and earnings growth, despite a slowdown in the biotech funding cycle [3] Market Position - Medpace Holdings, Inc. had a market capitalization of $15.715 billion as of December 12, 2025, with shares closing at $557.90 [2] - The number of hedge funds holding Medpace increased from 42 to 43 in the third quarter [4] - Despite its potential, the company is not among the 30 most popular stocks among hedge funds, and certain AI stocks are considered to offer greater upside potential [4]